These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 27498003)

  • 1. MiR-509-3-5p causes aberrant mitosis and anti-proliferative effect by suppression of PLK1 in human lung cancer A549 cells.
    Wang XH; Lu Y; Liang JJ; Cao JX; Jin YQ; An GS; Ni JH; Jia HT; Li SY
    Biochem Biophys Res Commun; 2016 Sep; 478(2):676-82. PubMed ID: 27498003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-296-5p suppresses cell viability by directly targeting PLK1 in non-small cell lung cancer.
    Xu C; Li S; Chen T; Hu H; Ding C; Xu Z; Chen J; Liu Z; Lei Z; Zhang HT; Li C; Zhao J
    Oncol Rep; 2016 Jan; 35(1):497-503. PubMed ID: 26549165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-296-5p suppresses papillary thyroid carcinoma cell growth via targeting PLK1.
    Zhou SL; Tang QL; Zhou SX; Ren RZ
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2084-2091. PubMed ID: 30915753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of PLK1 through competition between hnRNPK, miR-149-3p and miR-193b-5p.
    Shin CH; Lee H; Kim HR; Choi KH; Joung JG; Kim HH
    Cell Death Differ; 2017 Nov; 24(11):1861-1871. PubMed ID: 28708135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-100 is a potential molecular marker of non-small cell lung cancer and functions as a tumor suppressor by targeting polo-like kinase 1.
    Liu J; Lu KH; Liu ZL; Sun M; De W; Wang ZX
    BMC Cancer; 2012 Nov; 12():519. PubMed ID: 23151088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-100 resensitizes docetaxel-resistant human lung adenocarcinoma cells (SPC-A1) to docetaxel by targeting Plk1.
    Feng B; Wang R; Chen LB
    Cancer Lett; 2012 Apr; 317(2):184-91. PubMed ID: 22120675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polo-like kinase 1 regulates cell proliferation and is targeted by miR-593* in esophageal cancer.
    Ito T; Sato F; Kan T; Cheng Y; David S; Agarwal R; Paun BC; Jin Z; Olaru AV; Hamilton JP; Selaru FM; Yang J; Matsumura N; Shimizu K; Abraham JM; Shimada Y; Mori Y; Meltzer SJ
    Int J Cancer; 2011 Nov; 129(9):2134-46. PubMed ID: 21170987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. USP7 is a novel Deubiquitinase sustaining PLK1 protein stability and regulating chromosome alignment in mitosis.
    Peng Y; Liu Y; Gao Y; Yuan B; Qi X; Fu Y; Zhu Q; Cao T; Zhang S; Yin L; Li X
    J Exp Clin Cancer Res; 2019 Nov; 38(1):468. PubMed ID: 31730000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of Polo like kinase 1 (PLK1) by p21(Waf1) mediates the p53-dependent prevention of caspase-independent mitotic death.
    Lin YC; Sun SH; Wang FF
    Cell Signal; 2011 Nov; 23(11):1816-23. PubMed ID: 21726628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PLK1 targets NOTCH1 during DNA damage and mitotic progression.
    De Blasio C; Zonfrilli A; Franchitto M; Mariano G; Cialfi S; Verma N; Checquolo S; Bellavia D; Palermo R; Benelli D; Screpanti I; Talora C
    J Biol Chem; 2019 Nov; 294(47):17941-17950. PubMed ID: 31597699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FRET-Based Sorting of Live Cells Reveals Shifted Balance between PLK1 and CDK1 Activities During Checkpoint Recovery.
    Lafranchi L; Müllers E; Rutishauser D; Lindqvist A
    Cells; 2020 Sep; 9(9):. PubMed ID: 32961751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-593-5p inhibit cell proliferation by targeting PLK1 in non small cell lung cancer cells.
    Yan L; Zhang Y; Li K; Wang M; Li J; Qi Z; Wu J; Wang Z; Ling L; Liu H; Wu Y; Lu X; Xu L; Zhu Y; Zhang Y
    Pathol Res Pract; 2020 Feb; 216(2):152786. PubMed ID: 31864714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of Polo-like kinase 1 by DNA damage in mitosis. Inhibition of mitotic PLK-1 by protein phosphatase 2A.
    Jang YJ; Ji JH; Choi YC; Ryu CJ; Ko SY
    J Biol Chem; 2007 Jan; 282(4):2473-82. PubMed ID: 17121863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of Plk1 regulation by miR-100 in human nasopharyngeal cancer.
    Shi W; Alajez NM; Bastianutto C; Hui AB; Mocanu JD; Ito E; Busson P; Lo KW; Ng R; Waldron J; O'Sullivan B; Liu FF
    Int J Cancer; 2010 May; 126(9):2036-48. PubMed ID: 19739117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of PLK1 inhibition on cisplatin-resistant gastric cancer cells.
    Chen Z; Chai Y; Zhao T; Li P; Zhao L; He F; Lang Y; Qin J; Ju H
    J Cell Physiol; 2019 May; 234(5):5904-5914. PubMed ID: 30488440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA miR-509 Regulates ERK1/2, the Vimentin Network, and Focal Adhesions by Targeting Plk1.
    Liao G; Wang R; Rezey AC; Gerlach BD; Tang DD
    Sci Rep; 2018 Aug; 8(1):12635. PubMed ID: 30135525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitivity of TP53-Mutated Cancer Cells to the Phytoestrogen Genistein Is Associated With Direct Inhibition of Plk1 Activity.
    Shin SB; Woo SU; Chin YW; Jang YJ; Yim H
    J Cell Physiol; 2017 Oct; 232(10):2818-2828. PubMed ID: 27861885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 Suppresses E2F1-dependent PLK1 expression upon DNA damage by forming p53-E2F1-DNA complex.
    Zhou Z; Cao JX; Li SY; An GS; Ni JH; Jia HT
    Exp Cell Res; 2013 Dec; 319(20):3104-15. PubMed ID: 24076372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effect of Polo-like kinase 1 depletion on mitosis and apoptosis of gastric cancer cells.
    Chen XH; Lan B; Qu Y; Zhang XQ; Cai Q; Liu BY; Zhu ZG
    World J Gastroenterol; 2006 Jan; 12(1):29-35. PubMed ID: 16440413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polo-like kinase 1 inhibitors, mitotic stress and the tumor suppressor p53.
    Sanhaji M; Louwen F; Zimmer B; Kreis NN; Roth S; Yuan J
    Cell Cycle; 2013 May; 12(9):1340-51. PubMed ID: 23574746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.